UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 139

Sortiert nach

Therapeutic vaccines for cancer: an overview of clinical trials

Nature reviews. Clinical oncology, 2014-09, Vol.11 (9), p.509-524

2014

Link zum Volltext

Verfügbarkeit prüfen

Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial

Journal of clinical oncology, 2012-10, Vol.30 (29), p.3640-3647

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer

Journal of clinical oncology, 2006-12, Vol.24 (34), p.5441-5447

2006

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2101-2107

2004

Link zum Volltext

Verfügbarkeit prüfen

Gefitinib for the treatment of non-small-cell lung cancer

Expert opinion on pharmacotherapy, 2010-06, Vol.11 (8), p.1343-1357

2010

Link zum Volltext

Verfügbarkeit prüfen

No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data

Value in health, 2009-09, Vol.12 (6), p.996-1003

2009

Link zum Volltext

Verfügbarkeit prüfen

First- and second-line treatment of advanced metastatic non-small-cell lung cancer: a global view

BMC proceedings, 2008-09, Vol.2 Suppl 2 (S2), p.S3-S3, Article S3

Thatcher, Nicholas

2008

Link zum Volltext

Verfügbarkeit prüfen

Improving Survival Without Reducing Quality of Life in Small-Cell Lung Cancer Patients by Increasing the Dose-Intensity of Chemotherapy With Granulocyte Colony-Stimulating Factor Support: Results of a British Medical Research Council Multicenter Randomized Trial

Journal of clinical oncology, 2000-01, Vol.18 (2), p.395-404

2000

Link zum Volltext

Verfügbarkeit prüfen

Ifosfamide, Carboplatin, and Etoposide With Midcycle Vincristine Versus Standard Chemotherapy in Patients With Small-Cell Lung Cancer and Good Performance Status: Clinical and Quality-of-Life Results of the British Medical Research Council Multicenter Randomized LU21 Trial

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8371-8379

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study

Clinical cancer research, 2019-04, Vol.25 (7), p.2088-2095

2019

Link zum Volltext

Verfügbarkeit prüfen

Maintenance and Consolidation Therapy in Patients with Unresectable Stage III/IV Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2010-10, Vol.15 (10), p.1034-1042

2010

Link zum Volltext

Verfügbarkeit prüfen

The place of targeted therapy in the patient management of non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2007-08, Vol.57, p.S18-S23

Thatcher, Nicholas

2007

Link zum Volltext

Verfügbarkeit prüfen

Response to Comments on “No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data”

Value in health, 2010, Vol.13 (5), p.683-683

2010

Link zum Volltext

Verfügbarkeit prüfen

Biosimilars: what the oncologist should know

Future oncology (London, England), 2019-04, Vol.15 (10), p.1147-1165

2019

Link zum Volltext

Verfügbarkeit prüfen

'Dos and don'ts' in the management of hyponatremia

Current medical research and opinion, 2015, Vol.31 (9), p.1755-1761

2015

Link zum Volltext

Verfügbarkeit prüfen

The diagnosis and management of inpatient hyponatraemia and SIADH

European journal of clinical investigation, 2015-08, Vol.45 (8), p.888-894

2015

Link zum Volltext

Verfügbarkeit prüfen

Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study

Clinical cancer research, 2019-05, Vol.25 (10), p.3193-3193

2019

Link zum Volltext

Verfügbarkeit prüfen

Survival improvement in thoracic cancer: progress from the last decade and beyond

Lung cancer (Amsterdam, Netherlands), 2007-08, Vol.57, p.S3-S5

2007

Link zum Volltext

Verfügbarkeit prüfen

The place of targeted therapy in the patient management of non-small cell lung cancer: Achieving survival improvement in thoracic tumours: from therapeutic strategy management to pharmacogenomics

Lung cancer (Amsterdam, Netherlands), 2007, Vol.57

THATCHER, Nicholas

2007

Link zum Volltext

Verfügbarkeit prüfen

Use of Hematopoietic Progenitors in Whole Blood to Support Dose-Dense Chemotherapy: A Randomized Phase II Trial in Small-Cell Lung Cancer Patients

Journal of clinical oncology, 2001-02, Vol.19 (3), p.712-719

2001

Link zum Volltext

Verfügbarkeit prüfen

Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010

Annals of oncology, 2011-07, Vol.22 (7), p.1507-1519

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Oral Topotecan in Advanced Non-Small Cell Lung Cancer

Clinical cancer research, 2000-03, Vol.6 (3), p.868

2000

Link zum Volltext

Verfügbarkeit prüfen

Achieving survival improvement in thoracic tumours: from therapeutic strategy management to pharmacogenomics

Lung cancer (Amsterdam, Netherlands), 2007-08, Vol.57, p.S1-S2

2007

Link zum Volltext

Verfügbarkeit prüfen

1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer

Annals of oncology, 2011-09, Vol.22 (9), p.1973-1980

2011

Link zum Volltext

Verfügbarkeit prüfen

Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2012-02, Vol.75 (2), p.261-267

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(126)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(82)
Life Sciences & Biomedicine
(70)
Humans
(69)
Oncology
(41)
Biological And Medical Sciences
(37)
Medical Sciences
(36)
Lung Neoplasms - Drug Therapy
(35)
Male
(35)
Female
(32)
Middle Aged
(27)
Aged
(26)
Adult
(25)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(25)
Pharmacology. Drug Treatments
(21)
Antineoplastic Agents
(17)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Chemotherapy
(17)
Lung Neoplasms - Mortality
(16)
Lung Neoplasms - Pathology
(15)
Pneumology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Therapeutic vaccines for cancer: an overview of clinical trials

Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial

Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer

Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study

Gefitinib for the treatment of non-small-cell lung cancer

No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data

First- and second-line treatment of advanced metastatic non-small-cell lung cancer: a global view

Improving Survival Without Reducing Quality of Life in Small-Cell Lung Cancer Patients by Increasing the Dose-Intensity of Chemotherapy With Granulocyte Colony-Stimulating Factor Support: Results of a British Medical Research Council Multicenter Randomized Trial

Ifosfamide, Carboplatin, and Etoposide With Midcycle Vincristine Versus Standard Chemotherapy in Patients With Small-Cell Lung Cancer and Good Performance Status: Clinical and Quality-of-Life Results of the British Medical Research Council Multicenter Randomized LU21 Trial

Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study

Maintenance and Consolidation Therapy in Patients with Unresectable Stage III/IV Non‐Small Cell Lung Cancer

The place of targeted therapy in the patient management of non-small cell lung cancer

Response to Comments on “No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data”

Biosimilars: what the oncologist should know

'Dos and don'ts' in the management of hyponatremia

The diagnosis and management of inpatient hyponatraemia and SIADH

Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study

Survival improvement in thoracic cancer: progress from the last decade and beyond

The place of targeted therapy in the patient management of non-small cell lung cancer: Achieving survival improvement in thoracic tumours: from therapeutic strategy management to pharmacogenomics

Use of Hematopoietic Progenitors in Whole Blood to Support Dose-Dense Chemotherapy: A Randomized Phase II Trial in Small-Cell Lung Cancer Patients

Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010

Phase II Study of Oral Topotecan in Advanced Non-Small Cell Lung Cancer

Achieving survival improvement in thoracic tumours: from therapeutic strategy management to pharmacogenomics

1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer

Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma

Suchergebnisse filtern